SNES vs. MDGS, EVOK, TCON, SEEL, ZVSA, FNCH, SNGX, GBNHF, GTBP, and AEMD
Should you be buying SenesTech stock or one of its competitors? The main competitors of SenesTech include Xylo Technologies (MDGS), Evoke Pharma (EVOK), TRACON Pharmaceuticals (TCON), Seelos Therapeutics (SEEL), ZyVersa Therapeutics (ZVSA), Finch Therapeutics Group (FNCH), Soligenix (SNGX), Greenbrook TMS (GBNHF), GT Biopharma (GTBP), and Aethlon Medical (AEMD). These companies are all part of the "medical" sector.
Xylo Technologies (NASDAQ:MDGS) and SenesTech (NASDAQ:SNES) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership, community ranking and analyst recommendations.
SenesTech received 316 more outperform votes than Xylo Technologies when rated by MarketBeat users. However, 100.00% of users gave Xylo Technologies an outperform vote while only 65.31% of users gave SenesTech an outperform vote.
SenesTech has a consensus target price of $3.50, suggesting a potential upside of 326.78%.
SenesTech has lower revenue, but higher earnings than Xylo Technologies.
Xylo Technologies has a net margin of 0.00% compared to Xylo Technologies' net margin of -646.27%. SenesTech's return on equity of 0.00% beat Xylo Technologies' return on equity.
Xylo Technologies has a beta of 0.31, indicating that its share price is 69% less volatile than the S&P 500. Comparatively, SenesTech has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500.
0.3% of Xylo Technologies shares are owned by institutional investors. Comparatively, 5.2% of SenesTech shares are owned by institutional investors. 2.2% of Xylo Technologies shares are owned by company insiders. Comparatively, 5.3% of SenesTech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, SenesTech had 3 more articles in the media than Xylo Technologies. MarketBeat recorded 3 mentions for SenesTech and 0 mentions for Xylo Technologies. SenesTech's average media sentiment score of 0.00 equaled Xylo Technologies'average media sentiment score.
Summary
SenesTech beats Xylo Technologies on 6 of the 11 factors compared between the two stocks.
Get SenesTech News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNES and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SNES and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SenesTech Competitors List
Related Companies and Tools
